CINECA IRIS Institutional Research Information System

SALERNO, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.276
AS - Asia 4.613
EU - Europa 3.911
SA - Sud America 581
Continente sconosciuto - Info sul continente non disponibili 272
AF - Africa 212
OC - Oceania 21
Totale 18.886
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.991
IT - Italia 1.516
SG - Singapore 1.385
CN - Cina 1.189
HK - Hong Kong 616
SE - Svezia 586
VN - Vietnam 582
BR - Brasile 462
DE - Germania 454
BG - Bulgaria 229
GB - Regno Unito 210
TR - Turchia 204
CA - Canada 201
FR - Francia 171
FI - Finlandia 166
JP - Giappone 149
AT - Austria 141
IN - India 126
RU - Federazione Russa 120
UA - Ucraina 111
KR - Corea 87
CI - Costa d'Avorio 55
BD - Bangladesh 41
CH - Svizzera 38
MX - Messico 38
NL - Olanda 36
IQ - Iraq 35
NG - Nigeria 34
PK - Pakistan 33
ZA - Sudafrica 32
AR - Argentina 31
ID - Indonesia 26
BE - Belgio 24
SN - Senegal 24
PL - Polonia 23
ES - Italia 21
VE - Venezuela 19
AU - Australia 17
CO - Colombia 17
EC - Ecuador 17
UZ - Uzbekistan 17
JO - Giordania 16
CZ - Repubblica Ceca 15
EG - Egitto 15
KE - Kenya 15
SA - Arabia Saudita 15
IE - Irlanda 10
MA - Marocco 10
MY - Malesia 10
PE - Perù 10
AZ - Azerbaigian 9
CL - Cile 9
KZ - Kazakistan 9
CR - Costa Rica 8
DZ - Algeria 8
JM - Giamaica 8
TW - Taiwan 8
PH - Filippine 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
HN - Honduras 6
OM - Oman 6
UY - Uruguay 6
IL - Israele 5
IR - Iran 5
LB - Libano 5
ET - Etiopia 4
GE - Georgia 4
HU - Ungheria 4
LT - Lituania 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
KH - Cambogia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
BB - Barbados 2
GA - Gabon 2
ME - Montenegro 2
MN - Mongolia 2
NP - Nepal 2
PR - Porto Rico 2
QA - Qatar 2
SI - Slovenia 2
SO - Somalia 2
SV - El Salvador 2
ZM - Zambia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
Totale 18.588
Salva come PNG Salva come JPEG
Città #
Ashburn 993
Singapore 800
Woodbridge 746
Ann Arbor 631
San Jose 619
Houston 608
Hong Kong 590
Serra 508
Santa Clara 481
Chandler 440
Fairfield 404
Dallas 348
Milan 290
Council Bluffs 283
Beijing 236
Shanghai 228
Sofia 228
New York 195
Seattle 183
Wilmington 174
Ho Chi Minh City 170
Los Angeles 153
Jacksonville 144
Izmir 138
Ottawa 133
Boardman 132
Cambridge 129
Hanoi 119
Hefei 119
Vienna 115
Princeton 111
Lawrence 97
Lauterbourg 94
Tokyo 87
Frankfurt am Main 86
Seoul 86
London 85
Nanjing 79
Medford 78
Pisa 63
Des Moines 57
Helsinki 57
Abidjan 55
Buffalo 52
Dong Ket 52
Istanbul 51
Munich 50
Dearborn 47
São Paulo 47
Rho 45
Rome 43
Redondo Beach 41
Columbus 35
Düsseldorf 33
Boulder 31
Lagos 31
Turku 30
Bremen 29
Da Nang 27
Bern 26
Chicago 26
Jüchen 25
Pune 25
Brussels 24
Dakar 24
Florence 24
Redwood City 24
Kunming 23
Nanchang 23
San Diego 23
Baltimore 22
San Francisco 21
Changsha 20
The Dalles 20
Livorno 19
Orem 19
Toronto 19
Washington 19
Fuzhou 18
Ogden 18
Belo Horizonte 17
Hebei 17
Johannesburg 17
Lucca 17
Nürnberg 17
Shenyang 17
Warsaw 17
Phoenix 16
Tashkent 16
Montreal 15
Amman 14
Atlanta 14
Brooklyn 14
Aversa 13
Jinan 12
Manchester 12
Memphis 12
Nuremberg 12
Stockholm 12
Baghdad 11
Totale 12.770
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 427
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 284
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 283
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 254
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 252
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 238
TSPO Radioligands for Neuroinflammation: An Overview 232
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 222
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 220
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 219
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 218
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 217
An update into the medicinal chemistry of translocator protein (TSPO) ligands 217
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 215
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 215
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 213
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 212
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 211
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 208
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 208
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 206
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 205
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 204
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 203
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 203
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 202
Synthesis, DNA binding and in vitro antiproliferative activity of purinoquinazoline, pyridopyrimidopurine and pyridopyrimidobenzimidazole derivatives as potential antitumor agents 201
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 201
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 199
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 197
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 197
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 196
Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity 195
Synthesis of Purinobenzodiazepine and Purinobenzotriazocine derivatives, two new heterocyclic ring systems. 194
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 193
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 193
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 188
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 187
FACILE SYNTHESIS OF 3-SUBSTITUTED[1,2,4]TRIAZINO[3,4-F]PURINE-4,6,8-TRIONE DERIVATIVES 184
Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model 184
Synthesis of novel pyrido[3',2':5,6]thiopyrano[3,2-b]indol-5(6H)-ones and 6H-pyrido[3',2':5,6]thiopyrano[4,3-b]quinolines,two new heterocyclic systems. 182
Pyrazolo[3,4,-d]pyrimidine-4-one Derivatives as Novel and Potent Inhibitors of Adenosine Deaminase 182
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 182
Mitochondrial permeability transition induced by novel pyridothiopyranopyrimidine derivatives: Potential new antimitochondrial antitumour agents. 179
Carbonic anhydrase activation profile of indole-based derivatives 179
Synthesis and antiproliferative evaluation of new aryl substituted Pyrido[3’,2’:5,6]thiopyrano[4,3-c]pyrazoles 177
Synthesis of novel 1,4-dihydropyrido[3’,2’:5,6]thiopyrano[4,3-c]-pyrazoles and 5H-pyrido[3’,2’:5,6]thiopyrano[4,3-d]pyrimidines as potential antiproliferative agents 176
Synthesis of Pyrimido[1,2-a]benzimidazol-4(10H)-one Derivatives and Evaluation of their Interactions with DNA 176
Microwave-assisted Suzuki Coupling in Aqueous Media: a Useful Tool for the Synthesis of 3-Arylindazole Derivatives 176
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 176
Novel Aldose Reductase Acetic acid Inhibitors Bearing a Five Membered heterocyclic core 175
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents 173
Synthesis and biological activity of 1,4-dihydrobenzothiopyrano[4,3-c]pyrazole derivatives, novel pro-apoptotic mitochondrial targeted agents 173
Derivati spiroidantoinici del Tiopirano[2,3-b]piridin-4(4H)-one quali potenti inibitori dell’aldoso reduttasi 169
Spirohydantoin Derivatives of Thiopyrano[2,3-b]pyridin-4(4H)-one as Potent in Vitro and in Vivo Aldose Reductase Inhibitors 169
Refinement of the translocator protein pharmacophore/receptor model via structure-activity relationships of novel N,N-dialkylindolylglyoxylamides 168
2-(phenylsulphonamido)-pyrazole derivatives as carbonic anhydrase inhibitors 167
Synthesis of New Heterocyclic Ring Systems via [1,3,5]Triazino[1,2-a]benzimidazole Derivatives 165
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry 164
Novel Antitumoral Pyrazolopyrimidines Based on Inhibition of Protein Tyrosine Kinase 163
Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities 162
3-Aryl-1,2,4-triazino-4,3-abenzimidazol-4(10H)-one: a novel template for the design of highly selective A2B adenosine receptor antagonists 161
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin Topoisomerase I (top1) inhibitors 159
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 159
"Synthesis of purinobenzodiazepine and purinobenzotriazocine derivatives, two new heterocyclic ring system" 157
1-(PHENYLSULPHONAMIDO)-PYRAZOLE DERIVATIVES AS CARBONIC ANHYDRASE INHIBITORS. 157
New oxazole and 1,2,4-oxadiazole derivatives as selective ligands at the Translocator Protein (TSPO) 156
Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs 156
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy-An Overview 154
Anxiolytic-like Effects of N,N-Dialkyl-2-phenylindol-3-ylglyoxylamides by Modulation of Translocator Protein Promoting Neurosteroid Biosynthesis 154
"Synthesis of pyridothiopyranoindole and of pyridothiopyranoquinoline derivatives as novel tetracyclic ring system" 151
Design, Synthesis, and Biological Evaluation of 3-Arylindazole Acetic Acid Derivatives as Aldose Reductase Inhibitors 150
Exploiting the pyrazolo[3,4-d]pyrimidinone ring system as a useful template for the obtainment of potent adenosine deaminase inhibitors 150
Design, synthesis, and biological evaluation of novel fluorescent probes targeting the Translocator Protein (18 kDa) (TSPO) 150
Novel Irreversible Fluorescent Probes Targeting the 18 kDa Translocator Protein: Synthesis and Biological Characterization 149
Synthesis and biological evaluation of Modified 2-Phenylindol-3-ylglyoxylamides as good candidates for the development of radioligands for the visualization of peripheral benzodiazepine receptor 148
Benzoxadiazole Derivatives: Atypical Inhibitors of Aldose Reductase 146
Cancer Immunotherapy: An Overview on Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021) 145
Novel Pyrazolopyrimidine Derivatives as Therapeutic Agents for the Treatment of Medullary Thyroid Carcinoma 143
Pursuing Polypharmacology: Benzothiopyranoindoles as G-Quadruplex Stabilizers and Topoisomerase I Inhibitors for Effective Anticancer Strategies 141
Pyridopyrimidinone Derivatives as Novel Therapeutic Agents for the Topic Treatment of Vessel Walls Subjected to Percutaneous Intervention 139
SYNTHESIS OF NOVEL 5H,11H-PYRIDO[2',3':2,3]THIOPIRANO[4,3-B]-INDOLES BY FISCHER-INDOLE CYCLIZATION. 139
"Synthesis, DNA binding and in vitro antiproliferative activity of quinazobenzimidazole derivatives as potential antitumor agents". 138
Tricyclic Sulfonamides Incorporating Benzothiopyrano[4,3-c]pyrazole and Pyridothiopyrano[4,3-c]pyrazole Effectively Inhibit a- and ß-Carbonic Anhydrase: X-ray Crystallography and Solution Investigations on 15 Isoforms 138
Targeting the Translocator protein (TSPO) with 2-phenylindol-3-ylglyoxylamide derivatives 135
High Affinity Central Benzodiazepine Receptor Ligands: Synthesis and Biological Evaluation of a Series of Phenyltriazolobenzotriazindione Derivatives (PTBTs) 134
New suitable scaffolds for the development of non camptothecin topoisomerase I (Top1) inhibitors 134
NOVEL KINASE INHIBITORS IN THYROID CANCER TREATMENT: SYNTHESIS AND BIOLOGICAL EVALUATION 133
Synthesis, in vitro antiproliferative activity and DNA-interaction of benzimidazoquinazoline derivatives as potential anti-tumor agents 132
Synthesis and biological evaluation on human glioblastoma cells of novel pyrazolo[3,4-d]pyrimidine adenosine A(3) receptor antagonists. 131
Substituted 2-Arylindolglyoxylamides as Potent Translocator Protein (18 kDa) TSPO ligands: Synthesis and Biological Evaluation 131
Synthesis and Antiproliferative Activity of New Aminoalkyl Substituted Benzothiopyranoindoles 128
2-(Phenylamino)-7,8-dihydroquinazolin-5(6H)-one, a promising scaffold for MAO-B inhibitors with potential GSK3β targeting 125
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents 123
"Sintesi e attività antiproliferativa di sistemi Pirido[3’,2’:5,6]tiopirano[4,3-c]pirazolici 2-aril sostituiti" 122
Carbonic Anhydrase Activators for Neurodegeneration: An Overview 119
Novel 3-Aryl-1,2,4triazino4,3-abenzimidazol-4(10H)-ones (ATBI) as selective A2A adenosine receptor antagonists 115
Drug repurposing meets DNA independent pathways: targeting alternative substrates for anticancer therapy 114
"Facile sintesi di nuove molecole polieterocicliche a partire dal 2-guanidinobenzimidazolo" 113
Synthesis and in vitro Antiproliferative Activity of New Substituted Benzo[3',2':5,6]thiopyrano[4,3-d]pyrimidines 112
Totale 17.771
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.234
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.020 0 0 53 69 178 150 37 51 41 37 57 347
2022/20231.631 198 281 115 147 202 202 18 114 263 6 64 21
2023/20241.347 144 134 150 92 161 275 102 49 12 22 88 118
2024/20253.650 30 124 44 230 428 412 253 179 332 457 386 775
2025/20264.648 254 475 459 325 474 357 992 218 359 417 185 133
2026/20271.096 139 251 706 0 0 0 0 0 0 0 0 0
Totale 18.886